Foamix Pharmaceuticals Ltd. Retained Earnings
Foamix Pharmaceuticals Ltd. had Retained Earnings of -$310.59 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2020-03-12
- 2019-12-31: Retained Earnings (Accumulated Deficit) -$310.59M.
- 2019-09-30: Retained Earnings (Accumulated Deficit) -$272.77M.
- 2019-06-30: Retained Earnings (Accumulated Deficit) -$249.61M.
- 2019-03-31: Retained Earnings (Accumulated Deficit) -$230.61M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2019-12-31 | -$310.59M 10-K · filed 2020-03-12 |
| 2019-09-30 | -$272.77M 10-Q · filed 2019-11-12 |
| 2019-06-30 | -$249.61M 10-Q · filed 2019-08-07 |
| 2019-03-31 | -$230.61M 10-Q · filed 2019-05-07 |
| 2018-12-31 | -$215.41M 10-K · filed 2020-03-12 |
| 2018-09-30 | -$201.33M 10-Q · filed 2018-11-07 |
| 2018-06-30 | -$185.85M 10-Q · filed 2018-08-08 |
| 2018-03-31 | -$167.22M 10-Q · filed 2018-05-08 |
| 2017-12-31 | -$141.28M 10-K · filed 2019-02-28 |
| 2017-06-30 | -$106.34M 6-K · filed 2017-08-08 |
| 2016-12-31 | -$75.57M 10-K · filed 2018-03-01 |
| 2016-06-30 | -$58.93M 6-K · filed 2016-08-10 |
| 2015-12-31 | -$46.23M 20-F · filed 2017-02-21 |
| 2015-06-30 | -$37.45M 6-K · filed 2015-10-19 |
| 2014-12-31 | -$29.71M 20-F · filed 2016-03-02 |
| 2013-12-31 | -$18.23M 20-F · filed 2015-03-17 |